• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC201000
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 09/28/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Concomitant medical products: as gore was unable to determine which device was involved in the event if any; additional device(s) implanted include: plc181200/11730835.
 
Event or Problem Description
On (b)(6) 2013 this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprosthesis featuring c3® delivery system.On (b)(6) 2021, the patient underwent reintervention for treatment of a distal type i endoleak due to proximal migration of a contralateral leg component back into the aneurysm sac.Disease progression was reported to have caused the device to regress back into the aneurysm sac.The endoleak was resolved with placement of an additional contralateral leg component.No aneurysm enlargement was reported just disease progression (elongation).
 
Additional Manufacturer Narrative
H6: code 3331, 213: the manufacturing records for the plc181200/(b)(6) verified the lot met all pre-release specifications.
 
Additional Manufacturer Narrative
B1: corrected adverse event selection.H6: added component code 515.H6: changed investigation conclusion from 4315 to 50.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
laura crawford
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12676888
Report Number3007284313-2021-01629
Device Sequence Number4212533
Product Code MIH
UDI-Device Identifier00733132618590
UDI-Public00733132618590
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Reporter Type Manufacturer
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/31/2016
Device Model NumberPLC201000
Device Catalogue NumberPLC201000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/28/2021
Supplement Date Received by Manufacturer09/28/2021
03/28/2022
Initial Report FDA Received Date10/21/2021
Supplement Report FDA Received Date01/10/2022
03/28/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/17/2013
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention; Other;
Patient Age83 YR
Patient SexMale
-
-